KRAS G12C inhibitor 29
KRAS G12C inhibitor 29 is a KRAS G12C inhibitor extracted from patent WO2021252339A1, compound 3. KRAS G12C inhibitor 29 can be used for the research of cancer[1].
Product Specifications
CAS Number
[847337-63-7]
UNSPSC
12352005
Target
Ras
Type
Reference compound
Related Pathways
GPCR/G Protein; MAPK/ERK Pathway
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/kras-g12c-inhibitor-29.html
Solubility
10 mM in DMSO
Smiles
O=C(N1CC2=C(F)C=CC=C2Cl)N(C)C3=C(N4C(N(C5=CC=CC(C)=C5)CCC4)=N3)C1=O
Molecular Formula
C23H21ClFN5O2
Molecular Weight
453.90
References & Citations
[1]Fan J, et, al. Substituted purine-2,6-dione compounds as kras inhibitors. WO2021252339A1.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
More Discoveries
Explore Other Products
Browse additional items from our catalog
K4440907 1.0 µg DNA
Rarres2 sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 2)
Sign In for Pricing
View Details 
290384-01 50 mg
(2R,3S) -2,3,4-Trihydroxy-gamma-butyrolactone 2,3-cyclohexyl ketal
Sign In for Pricing
View Details 290384-02 100 mg
(2R,3S) -2,3,4-Trihydroxy-gamma-butyrolactone 2,3-cyclohexyl ketal
Sign In for Pricing
View Details